Smith & Nephew stock steadies after a buy call
Published on 08/24/2026 at 20:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Smith & Nephew (ISIN GB0009223206) stock drew attention on August 24, 2026 after Wall Street Zen upgraded the shares to Buy and a market snapshot showed the opening price at $29.29, near the 52-week low of $28.56.
The same update put the average analyst price target at $30.93, a narrow gap of $1.64 from the opening level. That keeps valuation and sentiment in close view for investors tracking the name.
Price action stays tight
A recent quote snapshot also showed a five-day move of +1.22% and a year-to-date change of -13.79% for the London line of the stock. In the same data set, the implied US-dollar price was $17.57, while the London price was 1,078.50 GBX.
The numbers point to a stock that has recovered only partly from the start of the year. The contrast between the small five-day gain and the double-digit year-to-date decline is the clearest comparison in the latest data.
Consensus still matters
Analyst positioning remains a useful reference point after the upgrade, because the quoted average target sits only modestly above the opening price. A target of $30.93 against $29.29 leaves limited room before the stock reaches that consensus level.
For holders, the main question is whether the shares can hold above the lower end of the recent range while the sentiment tone improves. The stock near $29.29 sits just $0.73 above the 52-week low of $28.56.
Product line
Smith & Nephew sells orthopaedics, sports medicine, and wound care products, including knee and hip implants, trauma systems, and advanced dressings. Those categories remain the core of the business model behind the stock.
Latest trading level
As of August 24, 2026, the stock was quoted at $29.29 at the open, with the 52-week low at $28.56 and the average analyst target at $30.93. The London quote in the same data set was 1,078.50 GBX.
Fact box
Company: Smith & Nephew plc
ISIN: GB0009223206
Ticker: SN, SNN
Exchange: LSE, NYSE ADR
Price (as of August 24, 2026, 10:39 a.m. AEST): 1,078.50 GBX
Market cap: not stated in the cited snapshot
Sector / Industry: Health Care / Medical Devices
View from the tape
Smith & Nephew stock sits close to a one-month pressure point after the upgrade and the latest quote snapshot. The spread between $29.29 and the $30.93 target leaves the market watching whether sentiment can improve faster than the year-to-date trend.
